亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

隨州市紅旗化工有限公司  

醫藥原料醫藥中間體原料藥

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:閆先生
  • 電話:0722-3257386
  • 傳真:0722-3257381
  • QQ:1374834438
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 磷酸奧司他韋CAS: 204255-11-8
磷酸奧司他韋CAS: 204255-11-8
單價 面議對比
詢價 暫無
發貨 湖北隨州市付款后3天內
型號 204255-11-8
過期 長期有效
更新 2020-06-18 10:09
 
詳細信息
磷酸奧司他韋
CAS: 204255-11-8 
中文同義詞: (3R,4R,5S)-4-乙酰胺基-5-氨基-3-(1-乙基丙氧基)-1-環己烯-1-羧酸乙酯磷酸鹽;磷酸奧司他韋;磷酸奧斯他韋
英文名稱: Oseltamivir phosphate
英文同義詞: ethyl (3r,4r,5s)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate phosphate;OSELTAMIVIR PHOSPHATE;NTERMEDIATES OF OSELTAMIVIR;Osteltamivir phosphate
分子式: C16H31N2O8P
分子量: 410.4
標準:cp
含量:99.5%
性狀:白色結晶性粉末
用途:是一種非常有效的流感治療用藥,并且可以大大減少并發癥(主要是氣管與支氣管炎、肺炎、咽炎等)的發生和抗生素的使用,因而是目前治療流感的最常用藥物之一,也是公認的抗禽流感、甲型H1N1病毒最有效的藥物之一。
包裝:根據客戶要求包裝
©2025 隨州市紅旗化工有限公司 版權所有   技術支持:化工網   訪問量:31021  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |